Clearside Biomedical Inc diskutieren
Clearside Biomedical Inc
WKN: A2ALP6 / Symbol: CLSD / Name: Clearside / Aktie / Micro Cap /
0,89 €
-
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Ratings data for CLSD provided by MarketBeat
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Ratings data for CLSD provided by MarketBeat
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $4.00 price target on the stock.
Ratings data for CLSD provided by MarketBeat
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $4.00 price target on the stock.
Ratings data for CLSD provided by MarketBeat
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Ratings data for CLSD provided by MarketBeat
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $5.00 price target on the stock.
Ratings data for CLSD provided by MarketBeat
Clearside Biomedical, Inc. (NASDAQ: CLSD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CLSD provided by MarketBeat
Clearside Biomedical, Inc. (NASDAQ: CLSD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CLSD provided by MarketBeat
Clearside Biomedical, Inc. (NASDAQ: CLSD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CLSD provided by MarketBeat
Clearside Biomedical, Inc. (NASDAQ: CLSD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CLSD provided by MarketBeat
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Ratings data for CLSD provided by MarketBeat
Clearside Biomedical, Inc. (NASDAQ: CLSD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CLSD provided by MarketBeat
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Ratings data for CLSD provided by MarketBeat
Clearside Biomedical, Inc. (NASDAQ: CLSD) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for CLSD provided by MarketBeat
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $4.00 price target on the stock, down previously from $5.00.
Ratings data for CLSD provided by MarketBeat
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $4.00 price target on the stock.
Ratings data for CLSD provided by MarketBeat
Clearside Biomedical, Inc. (NASDAQ: CLSD) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for CLSD provided by MarketBeat
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $4.00 price target on the stock.
Ratings data for CLSD provided by MarketBeat
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its price target lowered by analysts at HC Wainwright from $6.00 to $5.00. They now have a "buy" rating on the stock.
Ratings data for CLSD provided by MarketBeat
Clearside Biomedical, Inc. (NASDAQ: CLSD) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $5.00 price target on the stock.
Ratings data for CLSD provided by MarketBeat
Neueste Beiträge
HC_Wainwright in Edap Tms S.A. ADR diskutieren